Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Insulin biphasic isophane (Novo-Nordisk)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mixtard 30 Penfill 100units/ml inj 3ml cartridges
0601012D0BCBABA
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | 1 |
|
Human Mixtard 10 Penfill 100units/ml inj 1.5ml cartridges
0601012D0BCAMBJ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Human Mixtard 20 Penfill 100units/ml inj 1.5ml cartridges
0601012D0BCANBE
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Human Mixtard 30 Penfill 100units/ml inj 1.5ml cartridges
0601012D0BCALAJ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Human Mixtard 40 Penfill 100units/ml inj 1.5ml cartridges
0601012D0BCAPBL
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Human Mixtard 50 100units/ml inj 10ml vials
0601012D0BCAXA4
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Human Mixtard 50 Penfill 100units/ml inj 1.5ml cartridges
0601012D0BCAQA2
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 10 NovoLet 100units/ml suspension for injection
0601012D0BCASBQ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 10 Penfill 100units/ml inj 3ml cartridges
0601012D0BCAYBI
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 20 NovoLet 100units/ml suspension for injection
0601012D0BCATA3
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 20 Penfill 100units/ml inj 3ml cartridges
0601012D0BCAZAZ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 30 100units/ml suspension for injection 10ml vials
0601012D0BCAWAG
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 30 InnoLet 100units/ml inj 3ml pre-filled pens
0601012D0BCBDBZ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 30 NovoLet 100units/ml suspension for injection
0601012D0BCARBZ
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 40 NovoLet 100units/ml suspension for injection
0601012D0BCAUBH
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 40 Penfill 100units/ml inj 3ml cartridges
0601012D0BCBBBK
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 50 NovoLet 100units/ml suspension for injection
0601012D0BCAVBX
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Mixtard 50 Penfill 100units/ml inj 3ml cartridges
0601012D0BCBCBU
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
|
Pork Mixtard 30 100units/ml inj 10ml vials
0601012D0BCABAI
|
Insulin biphasic isophane (Novo-Nordisk) | Biphasic isophane insulin | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.